A Study of Mirikizumab Solution (LY3074828) in Healthy Participants

NCT07446101 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Mirikizumab

Sponsor

Eli Lilly and Company